In cancer cells, Bax activation by BH3 proteins is limited by the overexpression of anti-apoptotic proteins, such as Bcl-xL, leading us to investigate if Tom22 was still involved in Bax activation in the presence of Bcl-xL. Here, BAX is linked to cancer.